Fabien Zoulim, Claire Fournier, François Habersetzer, Martin Sprinzl, Stanislas Pol, Carla S Coffin, . . . Geneviève Inchauspé. (2020). Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: A phase 1b placebo-controlled trial. Taylor & Francis Group.
Chicago Style (17th ed.) CitationFabien Zoulim, et al. Safety and Immunogenicity of the Therapeutic Vaccine TG1050 in Chronic Hepatitis B Patients: A Phase 1b Placebo-controlled Trial. Taylor & Francis Group, 2020.
MLA (9th ed.) CitationFabien Zoulim, et al. Safety and Immunogenicity of the Therapeutic Vaccine TG1050 in Chronic Hepatitis B Patients: A Phase 1b Placebo-controlled Trial. Taylor & Francis Group, 2020.
Warning: These citations may not always be 100% accurate.